Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New history entry added: Revision: v3.3.3; removed items from the history include HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T13:33:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page shows a minor site revision from v3.2.0 to v3.3.2 with no changes to trial data, study descriptions, or links. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:41:15.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed the banner about government funding lapses and related operating status updates on the page.
    Difference
    0.8%
    Check dated 2025-11-17T17:38:37.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The update shows minor visual adjustments to the Record History page and the version list; there are no changes to core trial data such as status, description, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T12:30:33.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    12%
    Check dated 2025-10-05T17:27:19.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T10:10:28.000Z thumbnail image

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.